Cargando…
Next-generation antigen-presenting cell immune therapeutics for gliomas
Antigen presentation machinery and professional antigen-presenting cells (APCs) are fundamental for an efficacious immune response against cancers, especially in the context of T cell–centric immunotherapy. Dendritic cells (DCs), the gold standard APCs, play a crucial role in initiating and maintain...
Autores principales: | Lee-Chang, Catalina, Lesniak, Maciej S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888388/ https://www.ncbi.nlm.nih.gov/pubmed/36719372 http://dx.doi.org/10.1172/JCI163449 |
Ejemplares similares
-
Next-generation sequencing: insights to advance clinical investigations of the microbiome
por: Wensel, Caroline R., et al.
Publicado: (2022) -
Lessons learned: next-generation sequencing applied to undiagnosed genetic diseases
por: Schuler, Bryce A., et al.
Publicado: (2022) -
Impact of epigenetic reprogramming on antitumor immune responses in glioma
por: McClellan, Brandon L., et al.
Publicado: (2023) -
Therapeutic targets for cardiac fibrosis: from old school to next-gen
por: Travers, Joshua G., et al.
Publicado: (2022) -
Next-generation sequencing: unraveling genetic mechanisms that shape cancer immunotherapy efficacy
por: Halima, Ahmed, et al.
Publicado: (2022)